PRE-FUNDED COMMON STOCK PURCHASE WARRANT NEKTAR THERAPEUTICSNektar Therapeutics • March 4th, 2024 • Pharmaceutical preparations
This Warrant is issued pursuant to that certain Securities Purchase Agreement, dated March [ ], 2024, by and among the Company and the Purchaser identified therein (the “Purchase Agreement”). This Warrant and all new warrants, if any, issued by the Company pursuant to Section 4 hereof are referred to herein, collectively, as the “Warrants.”
NEKTAR THERAPEUTICS SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 4th, 2024 • Nektar Therapeutics • Pharmaceutical preparations • New York
THIS SECURITIES PURCHASE AGREEMENT (the “Agreement”) is made as of March 4, 2024 (the “Effective Date”), by and between NEKTAR THERAPEUTICS, a Delaware corporation (the “Company”), and TCG Crossover Fund II, L.P., a Delaware limited partnership (the “Purchaser”).
